Indatuximab ravtansine plus dexamethasone with lenalidomide or pomalidomide in relapsed or refractory multiple myeloma: a multicentre, phase 1/2a study
Titel:
Indatuximab ravtansine plus dexamethasone with lenalidomide or pomalidomide in relapsed or refractory multiple myeloma: a multicentre, phase 1/2a study
Auteur:
Kelly, Kevin R Ailawadhi, Sikander Siegel, David S Heffner, Leonard T Somlo, George Jagannath, Sundar Zimmerman, Todd M Munshi, Nikhil C Madan, Sumit Chanan-Khan, Asher Lonial, Sagar Chandwani, Suraj Minasyan, Ashot Ruehle, Markus Barmaki-Rad, Farima Abdolzade-Bavil, Afsaneh Rharbaoui, Faiza Herrmann-Keiner, Eva Haeder, Thomas Wartenberg-Demand, Andrea Anderson, Kenneth C